A new molecular entity, a constituent, and directions for use

Title:

A new molecular entity, a constituent, and directions for use

Document Type and Number:

Japanese Patent JP5905934

Kind Code:

B2

Abstract:

Described herein are compounds useful in the modulation of blood uric acid levels, formulations containing them and methods of using them. In some embodiments, the compounds described herein are used in the treatment or prevention of disorders related to aberrant levels of uric acid.

More Like This:

JP2011506539	Azolylmethyloxylanes, their use and compositions containing them
WO/2019/086494	BICYCLIC SULFONES AND SULFOXIDES AND METHODS OF USE THEREOF
WO/2021/239165	PEPTIDE FOR TREATING CORONAVIRUS INFECTIONS

Inventors:

Quart Barry Dee.
Girardet Gene-Rack
Gnich esmill
Yeretain

Application Number:

JP2014150149A

Publication Date:

April 20, 2016

Filing Date:

July 23, 2014

Export Citation:

Click for automatic bibliography generation Help

Assignee:

Aldea Biosciences Inc.

International Classes:

A61K31/4196; A61P19/06

Domestic Patent References:

JP2012184234A

Foreign References:

WO2006026356A1

Attorney, Agent or Firm:

Kazuhiro Kiyohara

Previous Patent: An exhaust-heat recovery device and the exhaust-heat recovery method

Next Patent: The fueling system for an internal-combustion engine